Literature DB >> 1391458

Preparation and characterization of diaspirin cross-linked hemoglobin solutions for preclinical studies.

D Nelson1, M Azari, R Brown, K Burhop, S Bush, J Catarello, H Chuang, C Downing, T Estep, A Loewen.   

Abstract

During 1990 and 1991 the capability for repetitive, consecutive production of DCLHb solution to meet a rigorous and complete set of product criteria was demonstrated. In addition, through periodic monitoring of product stored under controlled conditions, the stability of all lots of DCLHb solution during frozen storage was demonstrated for more than a year. In this way, assurance was provided that the DCLHb solution used in preclinical testing met all product criteria throughout the biological testing period.

Mesh:

Substances:

Year:  1992        PMID: 1391458     DOI: 10.3109/10731199209119662

Source DB:  PubMed          Journal:  Biomater Artif Cells Immobilization Biotechnol        ISSN: 1055-7172


  3 in total

Review 1.  Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?

Authors:  Abdu I Alayash
Journal:  Biomolecules       Date:  2017-01-04

2.  Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.

Authors:  Abdu I Alayash
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

Review 3.  The Critical Choice of Animal Models in Nanomedicine Safety Assessment: A Lesson Learned From Hemoglobin-Based Oxygen Carriers.

Authors:  Peter Bedőcs; János Szebeni
Journal:  Front Immunol       Date:  2020-10-26       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.